iBio is a Developer
and Manufacturer of Biotherapeutics

iBio provides contract development and manufacturing services to clients from the early stages of product selection through regulatory approval and commercial product launch. iBio’s technology platform and facility capabilities are applicable to the development of monoclonal antibodies, biotherapeutics, ADCs, vaccines, and combination medical devices – and often provide significant time and value advantages over alternative development and manufacturing approaches.